Skip to content
value.today
AnGes, Inc. logo

AnGes, Inc.

4563.T
$142 Mlast known market cap, Mar 2026 — no current value
Compare
World rank
—
no current market cap
Revenue
$0 M
Dec-2020 ending year
value.today research
Net income
$-39 M
-13133.3% margin
value.today research
Employees
—

AnGes, Inc. in brief

AnGes, Inc. is a listed company in the Biotechnology industry, based in Japan. It was founded in 1999. Its last known market value was $142 M (March 2026); there is no current figure. In the year to Dec 2020 it had sales of $0 M and a net loss of $39 M. Its shares trade under the symbol 4563.T (Tokyo).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

AnGes, Inc. timeline

3 events, 1999–2008
  1. 1999
  2. 🏁
    · approximate
    Founded by Ryūichi Morishita
  3. 2002
  4. 🔔
    · approximate
    Initial public offering on Mothers as 4563
  5. 2008
  6. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.

Events of AnGes, Inc. from Wikidata and SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$401 M$803 M$1.2 B$1.6 B2020202120222023202420252026

World rank over time

▲ up 332 places since 2020
2020-01-01: #9810#9,81020202021-01-01: #6434#6,43420212022-01-07: #13927#13,92720222022-12-25: #19815#19,81520222023-07-30: #20177#20,17720232024-01-05: #21366#21,36620242026-03-08: #9478#9,4782026

Rank in Japan: #995 (Jan 2020) · #588 (Jan 2021) · #1,095 (Jan 2022) · #1,677 (Dec 2022) · #1,886 (Jul 2023) · #2,099 (Jan 2024) · #1,856 (Mar 2026)

Annual results

Revenue
$0 M
Operating income
—
Net income
$-39 M

Dec-2020 ending year

How AnGes, Inc. compares in Biotechnology

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
AnGes, Inc.🇯🇵$142 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Mar 8, 2026 (last known)
Annual results:
Dec-2020 ending year
Balance sheet:
Dec-2020 ending year
Profile updated:
Nov 15, 2026

Figures from value.today research, Wikidata.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at AnGes, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show AnGes, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about AnGes, Inc.? Suggest a correction